UK COVID-19 vaccine trial may fail due to low transmission in population
There is a 50% chance the trial may give 'no result.'
Vial 1 of Box 1. This is the vaccine candidate to be used in Phase 1 clinical trial at the Clinical Biomanufacturing Facility (CBF) in Oxford, Britain, April 2, 2020. Picture taken April 2, 2020(photo credit: SEAN ELIAS/HANDOUT VIA REUTERS)ByDONNA RACHEL EDMUNDS
